Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Cardiac Assist Devices And Equipment Industry Expected To Reach By 2029, Starting From 2025 Levels?
The domain of cardiac assist devices and associated equipment has experienced robust expansion lately, with projections indicating a rise from a valuation of $2.13 billion in 2024 to $2.35 billion the following year, reflecting a compound annual growth rate of 10.0%; this upward trajectory during the preceding years is traceable to several factors, notably the increasing incidence of cardiac arrhythmias, the demographic shift towards an older populace, ongoing advancements in clinical guidelines coupled with supportive research efforts, and the broader adoption of less invasive surgical techniques.
Growth projections for the market encompassing cardiac assist devices and related apparatus indicate robust expansion forthcoming; by the year 2029, this sector is anticipated to reach a valuation of $3.38 billion, propelled by a compound annual growth rate (CAGR) of 9.5%. This upswing during the projection timeframe is fundamentally driven by advancements such as personalized medical treatments, broader worldwide availability of healthcare services, the utilization of electrophysiology tools in managing heart insufficiency, and the adoption of hybrid procedural techniques. Key developments shaping the market throughout this forecast era encompass the incorporation of 4D mapping and visualization capabilities, the integration of artificial intelligence within electrophysiology applications, the emergence of regenerative medicine strategies, and the increasing prevalence of leadless cardiac pacing systems.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2401&type=smp
Which Factors And Drivers Are Influencing The Cardiac Assist Devices And Equipment Market In 2025?
The escalating incidence of cardiovascular ailments across both advanced and emerging nations is fueling a greater requirement for sophisticated cardiac assistance technologies and apparatus. As the necessity for detecting, overseeing, intervening early, and proactively avoiding these fatal conditions grows, so too does the market demand for cardiac support mechanisms. Illustratively, information from the American Heart Association, a non-profit entity situated in the US, suggests that nearly 45.1 percent of Americans are projected to be affected by some type of CVD by the year 2035. Financial projections anticipate the overall expenditure related to CVD will hit $1.1 trillion in that same year, separating into approximately $748.7 billion designated for direct medical expenses and an indirect cost burden estimated at $368 billion; consequently, the expanding occurrence of heart and blood vessel diseases acts as a principal engine propelling the expansion of the market for cardiac assist devices and related machinery.
What Are The Leading Segments Analyzed In The Cardiac Assist Devices And Equipment Market?
The cardiac assist devices and equipmentmarket covered in this report is segmented –
1) By Type: Ventricular Assist Devices (LVAD), Intra-Aotic Baloon Pumps, Total Artificial Heart
2) By Modality: Transcutaneous, Implantable
3) By Application: Hospital Pharmacies, Ambulatory Surgical Centres, Emergency Services
Subsegments:
1) By Ventricular Assist Devices (LVAD): Implantable LVADs, Externally Powered LVADs, Pediatric LVADs, Other LVADs
2) By Intra-Aortic Balloon Pumps: Disposable Intra-Aortic Balloon Pumps, Reusable Intra-Aortic Balloon Pumps
3) By Total Artificial Heart: Pneumatically Powered Total Artificial Heart, Electrically Powered Total Artificial Heart, Other Total Artificial Heart Types
What Are The Major Trends Driving The Growth Of The Cardiac Assist Devices And Equipment Market?
Leading firms within the realm of cardiac assist devices and related equipment are dedicating efforts toward pioneering novel offerings, exemplified by the CardioMEMS HF System, which aims to enhance care accessibility for the expanding population afflicted by heart failure. This CardioMEMS HF System constitutes a cardiac apparatus capable of wirelessly ascertaining and tracking both pulmonary artery pressure and pulse rate in individuals suffering from heart failure. As a specific illustration, in February of 2022, Abbott Laboratories, a medical technology corporation situated in the United States, secured authorization from the FDA for the CardioMEMS HF System, recognized as a diminutive implantable sensor designed for managing heart failure. The data gleaned from the CardioMEMS system empowers healthcare practitioners to inform therapeutic choices and oversee their heart failure patients’ conditions, potentially facilitating earlier interventions and mitigating admissions to hospitals due to heart failure complications.
Which Major Firms Are Strengthening Their Position In The Cardiac Assist Devices And Equipment Industry?
Major companies operating in the cardiac assist devices and equipment market include Abbot Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt Ltd., Calon Cardio-Technology Ltd., Cardiobridge GmbH, Balton Sp. Z O.O, Cardiac Assist Inc., Braile Biomedica Ltd., Circulite Inc., Cardiokinetix Inc., Evaheart Inc., Fineheart Sarl, Fresenius Medical Care Ag & Co. KGaA, Getinge Ab, GPB Life Science Holdings Llc, Jarvik Heart Inc., Medtronic plc, OregonHeart, Mitiheart Corporation, Procyrion Inc., Relianthreat Inc., Scandinavian Real Heart AB, Senko Medical Instrument Mfg. Co. Ltd., Syncardia Systems LLC, HeartWare International Inc., Cardiac Dimensions Inc., Cardiac Power Innovations, Cardiac Science Corporation, Cardionomic Inc., Carmat SA, CorWave SA, Edwards Lifesciences Corporation, Leviticus Cardio Ltd., LivaNova PLC, MicroMed Cardiovascular Inc., MyoCardioCare Inc., Novacor SA, Orqis Medical Corporation, Terumo Corporation, Thoratec Corporation, Ventracor Limited
Download The Full Report For Exclusive Market Findings:
Which Region Shows The Highest Potential For Future Expansion In The Cardiac Assist Devices And Equipment Market?
North America was the largest region in global cardiac assist devices and equipment market in 2024. Western Europe was the second-largest region in cardiac assist devices and equipment market. The regions covered in the cardiac assist devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request A Customized Version Of The Cardiac Assist Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2401&type=smp
Browse Through More Reports Similar to the Global Cardiac Assist Devices And Equipment Market 2025, By The Business Research Company
Cardiovascular Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025
Cardiovascular Medical Lasers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model